KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Income (2016 - 2025)

Idexx Laboratories has reported Net Income over the past 17 years, most recently at $248.2 million for Q4 2025.

  • Quarterly results put Net Income at $248.2 million for Q4 2025, up 14.82% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 19.33% YoY), and the annual figure for FY2025 was $1.1 billion, up 19.33%.
  • Net Income for Q4 2025 was $248.2 million at Idexx Laboratories, down from $274.6 million in the prior quarter.
  • Over the last five years, Net Income for IDXX hit a ceiling of $294.0 million in Q2 2025 and a floor of $132.0 million in Q2 2022.
  • Median Net Income over the past 5 years was $208.3 million (2021), compared with a mean of $210.8 million.
  • Biggest five-year swings in Net Income: soared 82.64% in 2021 and later plummeted 34.86% in 2022.
  • Idexx Laboratories' Net Income stood at $162.8 million in 2021, then rose by 5.8% to $172.2 million in 2022, then grew by 12.96% to $194.5 million in 2023, then rose by 11.12% to $216.1 million in 2024, then grew by 14.82% to $248.2 million in 2025.
  • The last three reported values for Net Income were $248.2 million (Q4 2025), $274.6 million (Q3 2025), and $294.0 million (Q2 2025) per Business Quant data.